Podcasts about camidge

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Alexandra Rink, PhD, a medical physicist at Princess Margaret Cancer Centre; a clinician scientist at the Princess Margaret Research Institute; and an associate professor in the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto in Canada. Drs Camidge and Rink discussed how Dr Rink's early career interest in forensics led her down the path toward becoming a medical physicist, how physics factor into radiation therapy delivery, and the importance of multidisciplinary collaboration to deliver optimal patient care.

In this episode, Dr Camidge is rejoined by Rahul Gosain, MD, MBA, the medical director of Wilmot Cancer Institute at Webster and director of Wilmot Cancer Institute Regional Infusion services, as well as an assistant professor of clinical medicine in the Department of Medicine, Hematology/Oncology at the University of Rochester in New York. Dr Gosain is also co-host of the podcast Oncology Brothers.

In this episode, Dr Camidge sits down with Michael Smylie, MBBS, FRCPC, a professor in the Department of Oncology in the Faculty of Medicine and Dentistry at the University of Alberta and a medical oncologist at the Cross Cancer Institute in Edmonton, Canada.  Drs Camidge and Smylie discussed Dr Smylie's experience treating patients who live in the Northwest Territories of Canada, including the challenges he encounters when providing oncology care to such a vast geographic area, unique considerations when treating a predominantly indigenous community, and how his own colon cancer diagnosis influenced his relationship with patients.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sits down with Rahul Gosain, MD, MBA, the medical director of Wilmot Cancer Institute at Webster and director of Wilmot Cancer Institute Regional Infusion services, as well as an assistant professor of clinical medicine in the Department of Medicine, Hematology/Oncology at the University of Rochester in New York. He is also co-host of the podcast Oncology Brothers. Drs Camidge and Gosain discuss how Dr Gosain's journey through medical school led him to his role as a community oncologist, the challenges he encountered during his early career that inspired him to fill a need for concise yet comprehensive educational resources, and how he harnessed social media and leveraged professional connections to create a podcast highlighting practice updates for up-and-coming oncology professionals.

In this episode, Dr Camidge sits down with Duncan McLaren, MBBS, BSc, FRCR, FRCP, a consultant clinical oncologist at Spire Edinburgh Hospitals Murrayfield and Shawfair Park, as well as a professor at the Edinburgh Cancer Research Centre at The University of Edinburgh in Scotland. Drs Camidge and McLaren discuss Dr McLaren's unconventional journey to medical school, his experience as a clinical oncologist with expertise across oncology disciplines, and how his clinical research focus works to change the course of radiation therapy for genitourinary cancers.

In this episode, Dr Camidge sits down with Douglas Ney, MD, a professor of neurology and neurosurgery, program director of the Neurology Residency Program, and vice-chair of Education in the Department of Neurology at the University of Colorado Cancer Center in Aurora.  Drs Camidge and Ney discuss Dr Ney's journey to becoming a neurologic oncologist, how the management of primary brain tumors differs from that of brain metastases in his practice, and his experience as a physician with Tourette syndrome.

In this episode, Dr Camidge sits down with Jeanne Fourie Zirkelbach, PhD, a clinical pharmacologist in the Office of Clinical Pharmacology in the Center for Drug Evaluation and Research at the FDA.  Drs Camidge and Zirkelbach discuss how Zirkelbach got her start in the pharmacokinetics field; her involvement with Project Optimus, an initiative by the FDA's Oncology Center of Excellence that works to reform dose-optimization and -selection paradigms in oncology drug development; and how her research with patient-reported outcomes emphasizes the importance of keeping patient needs, preferences, and experiences at the forefront of drug development to minimize the effects of cancer treatment on quality of life.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sits down with Kadrin Wilfong, MD, to discuss her career in the field of continuing medical education (CME). Dr Wilfong is the vice president of Medical Education at PeerView Institute for Medical Education in New York, New York.  Drs Camidge and Wilfong talk through Wilfong's multifaceted journey to medical school, how her passion for the medical field propelled her career in oncology-focused education, the ins and outs of developing CME, and how educational events and resources can make a difference in the care of patients with cancer. 

Camidge and Kahl reflect on the steps in Kahl's communications career that paved the way for her to become a leader in the medical journalism field.

Camidge and White discuss the intersections between White's head and neck cancer diagnosis and radiation oncology communications career.

Camidge and Cooper discuss key moments in Cooper's career as a chaplain, the focus of her writing and research about hospital chaplaincy, and the importance of meeting patients where they are when providing spiritual care.

Drs Camidge and Datta highlight the nuances of Dr Datta's career as a surgeon-scientist, the unexpected intersections between music and surgery, his research that aims to improve systemic therapies for pancreatic cancer that will in turn improve surgical operations, and more.

Drs Camidge and Arslan discuss Dr Arslan's experience providing emergency medical care and the curiosity that led him to pursue a career in industry.

Drs Camidge and Su spotlight the aspects of medicine that strengthened Dr Su's interest in practicing medical oncology, the ins and outs of delivering lung cancer care in China, how the COVID-19 pandemic has affected her outlook on life and her career goals, and more.

Drs Camidge and Rimel spotlight the steps along Dr Rimel's journey to becoming a gynecologic oncology surgeon, how her career is informed by her identity as a member of the LGBTQ community, the work she does to expand access to medical care for transgender patients, and more.

Drs Camidge and Rabinowitz discuss the balancing act between professional and personal life that Rabinowitz navigated when he was diagnosed with lung cancer; how he connected with the patients he cared for while receiving treatment for his own disease; and the importance of finding ways to help people throughout all stages of one's life and career.

Drs Camidge and Lewis talk through the ways that Dr Lewis' diagnosis of MEN-1 has affected his personal and professional life, the importance of seeking out patient perspectives when making treatment decisions, how social media can be leveraged to raise awareness about rare diseases and treatments, and more.

Camidge and Farmen talk through the intersections of patient advocacy for cancer and cerebral palsy, the story of Farmen's cancer diagnosis, the myriad people who rallied around Farmen during the early days of her disease and continue to provide support, and more.

Drs Camidge and Kelley discuss the ways Dr Kelley's passion for research guided his early career path.

Drs Camidge and Okuyama Sasaki discuss the unique features and goals of safety net hospitals; the formative educational experiences that shaped Dr Okuyama Sasaki's medical career; the dynamics at play when helping low-income patients access cancer treatments and resources; and more.

Drs Camidge and Leland discuss various roles in the biotechnology field and the intricacies of starting a biotechnology company.

Drs Camidge and Gerber highlight the ways that a liberal arts education can lay the foundation for a successful career in medicine; the benefits of personalized, faced-to-face patient connections over digital interactions; and the importance of keeping a humble and service-focused mindset when caring for patients.

Drs Camidge and McVeigh highlight the evolution of the clinical genetics field over time, the process of identifying pathogenic genetic variants, the difficulties of explaining genetic testing results to patients, and more.

In this episode of How This Is Building Me, Drs Camidge and Garon discuss the differences in lung cancer management and drug advancement between the United States and Asia and highlight other topline takeaways from the 2023 WCLC.

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

In this episode of ‘How This is Building Me,' Drs Camidge and Abbott discuss the road from bench scientist to biotechnology analyst, rules and regulations in the industry, and more.

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

In this episode of ‘How This is Building Me,' Dr Camidge is rejoined by Dr Cetnar to discuss the good, the bad, and the ugly of the lung cancer data that were presented at the 2023 ASCO Annual Meeting.

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

In this episode of How This Is Building Me, Drs Camidge and Weickhardt discuss the span of countries and institutions Dr Weickhardt's medical training and career has led him to, the ins and outs of becoming a practicing oncologist in Australia vs the United States, and the importance of discerning patient needs and preferences to earn patient trust and deliver effective, personalized care across the globe. 

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

In today's episode of ‘How This is Building Me,' Dr Camidge and Melissa reflect on the bond they share as oncologist and patient, the nuances of Melissa's transition to hospice care, and the importance of authentically framing her cancer narrative as one where challenges, grief, and gratitude can coexist.

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

In this episode of ‘How This is Building Me,' Camidge sits down with Jalal to discuss her transition from life in Jordan to Indianapolis, Indiana, the realities of being a mother in medicine, the importance of transparency in academia, and more.

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

Featuring perspectives from Dr D Ross Camidge, Dr Justin Gainor, Prof Benjamin Solomon and Prof Solange Peters, including the following topics: •      Evolving Understanding and Management of Non-Small Cell Lung Cancer (NSCLC) with Targeted Mutations (0:00) •      Adjuvant Therapy for Patients with NSCLC with Targetable Mutations (11:17) •      Family Planning for Patients with Cancer (23:50) •      Optimal Identification of ALK-Positive Metastatic NSCLC — Dr Camidge (30:33) •      Selection of First-Line Treatment for ALK-Positive NSCLC — Dr Gainor (49:22) •      Sequencing and Selection of Therapy for Relapsed/Refractory ALK-Positive NSCLC — Prof Peters (1:23:33) •      Managing Side Effects of ALK Tyrosine Kinase Inhibitors (TKIs) — Prof Solomon (1:39:14) •      Case: A woman in her early 40s with Stage IIIB ALK-positive NSCLC who received alectinib for more than 4 years — Dr Gainor (1:59:37) •      Case: A woman in her mid 50s who remains in complete response with lorlatinib after 4 years — Prof Solomon (2:03:52) •      Case: A woman in her early 60s with Stage IV NSCLC with ALK translocation who received lorlatinib followed by alectinib — Prof Peters (2:10:18) •      Case: A woman in her late 60s with ALK-positive NSCLC who continues to receive brigatinib after discontinuation of alectinib due to concerns of drug-induced pneumonitis — Dr Camidge (2:15:44) •      Case: A woman in her late 40s with NSCLC with an ALK fusion who received multiple ALK TKIs — Dr Gainor (2:21:11) •      Case: A man in his early 30s with ALK-positive NSCLC and brain metastases who continues to receive lorlatinib after 6 years — Prof Solomon (2:26:33) CME information and select publications

In this episode of ‘How This is Building Me,' Camidge sits down with Bauml to discuss the transition from academia to industry, reasons for the move, expectations for the future, and more.

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

On today's episode, meet Dr. Ross Camidge. Dr. Camidge has been the Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado since 2007. He earned his medical degree from University of Oxford, and his PhD from University of Cambridge after receiving his undergraduate degree at Oxford University. Beyond the medicine, Dr. Camidge and all members of his team also believe they should look after every patient, and their friends and family, as they would want their own friends and family to be looked after.

In the inaugural episode of ‘How This is Building Me,' Camidge sits down with Cetnar to discuss the ins-and-outs of defining personal and professional success, perceptions around sought-after accolades and accomplishments, the meaning behind mentoring, and more.

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

Emily Daniels arrived at the E.R. short of breath while pregnant with her second child to discover she had Stage IV lung cancer. She had never smoked a day in her life.  Emily’s diagnosis belongs to more than 50% of lung cancer cases without a definitive explainable cause. Did you know that lung cancer in non-smokers might be caused by exposure to radon, secondhand smoke, air pollution, and even wok smoke?  Had Emily been diagnosed 10 years ago, she would not be alive to tell us this story. In this episode, she is joined by her husband, Brian Daniels - former CU Buffs star — and her oncologist, Dr. Ross Camidge, a University of Colorado Anschutz Medical Campus trailblazing oncologist who pioneered a breakthrough treatment aimed at some rare types of lung cancer. The treatment consists of two targeted therapies that have kept Emily alive for the past three years.  Now a mother of two, Emily talks about what inspires her fight against her diagnosis and the risks she took while pregnant in order to keep her baby. Choosing not to be treated with chemotherapy at the time was “a major life choice.” Her tough choices beg the questions: What to make of your life when you are forced to live it in three-month chunks? What if Emily has years, or maybe decades, left to live? It is because of her children and because of the unanswered questions, that she has chosen to fight.  She organizes a golf tournament to fund lung cancer research and has raised $100k in the past three years. She also works with LUNGEvity, a non-profit organization focused solely on lung cancer awareness and research. For his part, Doctor Camidge remains hopeful. While he agrees that lung cancer is grossly under-funded  — it receives 1/10 of the funding received by breast cancer — he has trained his oncologist’s sights onto a smarter vision that includes personalized medication and the meticulous study of “molecular persistence,” or what makes cancer cells persist, so he can stop them from getting wise.  Emily still has a Stage IV diagnosis. But thanks to her and to Doctor Camidge’s persistence, she’s living a mostly normal life. She remains active in yoga, she is a mother to two healthy children, and in her free time, she has become a patient-advocate for lung cancer. Now that’s unstoppable! #UnstoppablePodcasts

Our Unstoppable podcast hosts, Les Shapiro and Vic Lombardi, are fighting the cancer fight. Both of them. What are the chances? In this chillingly honest six-month checkup, they get intimate about the last thing they want from their loved ones and the things that drive them crazy about having to live inside bodies they no longer recognize. What happens when your body is incompatible with your chemotherapy treatment? The side effects of fighting cancer aren’t what many of us think. As much as cancer affects you physically, it is the mind games that wear you down. “I’ve changed my diet,” says Vic. “I’m exercising harder than ever. Why can’t I stop coming back for tests?” he wants to know. For his co-host, Les, shame is the issue. “I didn’t want to show weakness,” he admits. “I wanted to be the exception. It turns out I’m not the exception.” Our hosts have told the stories of unstoppable athletes and Olympians holding medals in gritty thumbs-up poses who talk in fighter metaphors. Their biggest fear? That after the the arduous journey through chemotherapy, radiation, and reoccurrence, this disease will kill the storytellers. Many cancer stories are lost. It’s easy to shy away and to shut down. Our two cancer warriors are here to make sure that does not happen. They shy away from nothing as they tackle the hard-hitting questions others are afraid to ask. Which is why they invited their oncologist to this episode. And because coincidence looms larger than life, both are being treated at University of Colorado Anschutz Medical Campus. Les’ oncologist, Dr. Ross Camidge, Professor of Medicine-Medical Oncology at the University of Colorado School of Medicine, is no stranger to cancer, either. Dr. Camidge discusses with Les why his recent radiation treatments went sideways because of “The Shapiro Effect,” and the breakthrough program they started — making Les the first patient in the world to use this pioneering double-barreled medical approach. For anyone who wants to feel validated in their fears about the mental warfare that knows no rest, this podcast is like a 911 call from the cancer trenches. It is the stories that terrify and sadden us that can open us to questions that can inspire and transform our lives. How long do I have? That is the question our podcasts hosts keep asking themselves. And what is next for them? “I’m going lease to lease,” says Vic. That’s his next move as he awaits the next round of results. If only cancer would shut up for a day or two. #UnstoppablePodcasts

Dr Camidge talks to ecancertv at ASCO 2015 about new treatments for anaplastic lymphoma kinase (ALK) positive lung cancer, including alectinib and brigatinib.

Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.

Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.

Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.

Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.

Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.